ESSA Pharma (EPIX)

• Market cap: $68.4M
• 1 day: 0.65%
• 5 days: -3.14%
• 1 month: -8.33%
• 3 months: -12.00%
• 6 months: -76.09%
• Year to date: -15.85%
• 1 year: -82.01%
• 5 years: -61.50%
• 10 years: -99.19%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

Employees: 35

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

225% more call options, than puts

Call options by funds: $179K | Put options by funds: $55K

130% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 10

41% more funds holding

Funds holding: 32 [Q3] → 45 (+13) [Q4]

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

5.16% less ownership

Funds ownership: 79.11% [Q3] → 73.96% (-5.16%) [Q4]

72% less capital invested

Capital invested by funds: $213M [Q3] → $58.8M (-$154M) [Q4]